Amanote Research

Amanote Research

    RegisterSign In

Thromboangiitis Obliterans

Current Treatment Options in Rheumatology - Switzerland
doi 10.1007/s40674-016-0047-6
Full Text
Open PDF
Abstract

Available in full text

Categories
RheumatologyAllergyImmunology
Date

April 12, 2016

Authors
Ahmet Rüçhan AkarM. Bahadır İnanÇağdaş Baran
Publisher

Springer Science and Business Media LLC


Related search

Thromboangiitis Obliterans

2016English

Thromboangiitis Obliterans

British Journal of Surgery
Surgery
1969English

Thromboangiitis Obliterans

2016English

Thromboangiitis Obliterans

2013English

Thromboangiitis Obliterans (Buerger's Disease)

Orphanet Journal of Rare Diseases
MedicineGeneticsPharmacology
2006English

Thromboangiitis Obliterans (Buerger’s Disease)—Current Practices

International Journal of Inflammation
AllergyImmunology
2013English

Thromboangiitis Obliterans: A Rare Case Report

Demiroğlu Bilim University Florence Nightingale Journal of Medicine
2019English

Pyridinolcarbamate; Bradykinin Antagonist, in Patients Suffering From Arteriosclerosis Obliterans and Thromboangiitis Obliterans (Buerger's Disease)

Japanese Heart Journal
1965English

New Aspects of Thromboangiitis Obliterans (Von Winiwarter-Buerger’s Disease)

European Neurology
Neurology
1984English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2025 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy